Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Esaote S.p.A. turns 40 and is confirmed as a leading player in the world market for diagnostic imaging with ultrasound systems, magnetic resonance imaging and information technology for healthcare 2022-04-12 19:00
New Clinical Advisory Board to support PromarkerD global rollout 2022-04-12 16:04
Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer 2022-04-12 09:28
VenusP-Valve(TM) obtains CE marking under MDR and debuts in Europe as China's first valve product 2022-04-12 09:20
Strong Growth in Digital Health Powers MediHeroes, A Cross Border B2B Medical Platform 2022-04-12 09:00
ProstACT Update: TARGET Study Ethics Approval 2022-04-12 07:47
The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for the First-Line Treatment of Small Cell Lung Cancer Accepted by NMPA 2022-04-11 22:07
Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program 2022-04-11 19:00
APRINOIA Therapeutics received FDA clearance to initiate APNmAb005 Phase 1 clinical trial 2022-04-11 18:00
Frost & Sullivan Hails Sphere Fluidics for Enabling Efficient, Faster, and More Cost-effective Single-cell Analysis with Its Microfluidic Platforms 2022-04-11 18:00
Singapore-based women's healthcare company marks its first Financial Times ranking 2022-04-11 17:21
Successful Passing Of The EU Qualified Person Audit Of The Group's Manufacturing Facility For ReCOV In Taizhou 2022-04-11 16:05
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID 2022-04-11 12:35
Mental Health Matters: Calling for Better Insurance Coverage 2022-04-11 11:00
Honeywell Teams with AstraZeneca to Develop Next-Generation Respiratory Inhalers That Use Near-Zero Global Warming Potential Propellant 2022-04-11 09:00
Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022-04-11 08:30
Innovent Release Phase 1 Results of IBI322 (anti-PD-L1/CD47 bispecific antibody) in patients with advanced solid tumors at AACR Annual Meeting 2022 2022-04-11 08:14
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab 2022-04-11 06:51
Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis 2022-04-10 18:20
Bactiguard enters development partnership in the dental field 2022-04-08 22:54
1 213 214 215 216 217 739